Asthma Inhaler Device Market forecast 2027 expected to register a CAGR of 6.42% to reach USD 19,677.54 Million. Asthma inhaler devices are hand-held, portable devices that are used to deliver medicine to the lungs. Inhaler devices are mainly used to treat or prevent diseases of the airways, including asthma.
The prevalence rate of asthma is increasing tremendously. According to the World Health Organization (WHO), in December 2016, an estimated 235 million people had asthma globally. This high prevalence of asthma, growing need for rescue medication, and rising demand for metered-dose inhalers are expected to drive the market growth.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1653
The Global Asthma Inhaler Device Market has been segmented by Type, Mode of Operation, and End User
The market, based on type, has been bifurcated into the metered-dose inhaler, dry powder inhaler, and soft mist inhaler. The metered-dose inhaler is further sub-segmented into standard pressurized metered-dose inhalers, breath-actuated pressurized metered-dose inhalers, and metered-dose inhaler with a spacer.
Based on the mode of operation, the asthma inhaler device market has been segregated into manually operated inhaler devices and digitally operated inhaler devices.
The global asthma inhaler device market, based on end-user, has been segmented into hospitals & clinics, homecare and others.
The Global Asthma Inhaler Device Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas are likely to dominate the global asthma inhaler device market. This can be attributed to the increase in the incidence of asthma and the rising demand for metered-dose inhalers. Moreover, the adoption of smart inhalers by the population and increasing demand for advanced technologies is also expected to drive market growth.
The European market for asthma inhaler devices is expected to be the second-largest during the review period. The presence of major players such as GlaxoSmithKline PLC, AstraZeneca, and Boehringer Ingelheim, the rising adoption of respiratory inhalers by hospitals and patients in European countries and continuous efforts made by the European Academy of Allergy & Clinical Immunology to increase awareness about asthma, is expected to boost the growth of the regional market.
Asia-Pacific is estimated to be the fastest-growing market owing to the presence of rapidly developing economies of China, India, and South Korea. Moreover, the high prevalence of asthma, as well as other respiratory diseases, is also positively affecting market growth.
The market in the Middle East & Africa is expected to witness steady growth due to increasing cases of asthma and demand for better treatments in the Middle Eastern countries.
The Prominent Players in the Global Asthma Inhaler Device Market are GlaxoSmithKline plc (UK), Koninklijke Philips NV (Netherlands), AstraZeneca (UK), Cipla Inc. (India), Boehringer Ingelheim International GmbH (Germany), Beximco Pharmaceuticals Ltd (Bangladesh), Merck & Co., Inc. (the US), Teva Pharmaceutical Industries Ltd (Israel), Chiesi Farmaceutici SpA (Italy), and Medisol Lifescience Pvt. Ltd (India).
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/asthma-inhaler-device-market-1653